NCT01913977View on ClinicalTrials.gov

Clinical Study to Determine the Optimal Operation Parameters During CO2 Removal With the Abylcap® System

NACompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

February 20, 2014

Primary Completion Date

June 13, 2014

Study Completion Date

September 12, 2014

Conditions
ARDS (Acute Respiratory Distress Syndrome)Respiratory Acidosis
Interventions
DEVICE

Abylcap® System: blood flow (QB): 200mL/min; gas flow (QG):7L/min

Abylcap settings

DEVICE

Abylcap® System: blood flow (QB): 300mL/min; gas flow (QG):7L/min

Abylcap settings

DEVICE

Abylcap® System: blood flow (QB): 400mL/min; gas flow (QG):7L/min

Abylcap settings

DEVICE

Abylcap® System: blood flow (QB): 400mL/min; gas flow (QG):1.5L/min

Abylcap settings

DEVICE

Abylcap® System: blood flow (QB): 400mL/min; gas flow (QG):3L/min

Abylcap settings

DEVICE

Abylcap® System: blood flow (QB): 400mL/min; gas flow (QG):6L/min

Abylcap settings

DEVICE

Abylcap® System: blood flow (QB): 400mL/min; gas flow (QG):8L/min

Abylcap settings

Trial Locations (1)

9000

Ghent University Hospital, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT01913977 - Clinical Study to Determine the Optimal Operation Parameters During CO2 Removal With the Abylcap® System | Biotech Hunter | Biotech Hunter